Infection by bacteriophage ΦStaph1N drives the loss of β-lactam resistance in MRSA.
A. Schematic of the experimental setup. Drug-resistant (AbxR), phage-sensitive (PhageS) bacterial cultures are infected with phage. The population of infected cells is passaged and allowed to recover. The surviving cell population is resistant to phage infection (PhageR) but has evolved sensitivity to antibiotics (AbxS). B. ΦStaph1N infects MRSA strains MRSA252, MW2, and LAC (left panel). Following infection with ΦStaph1N, evolved cultures of the three MRSA strains are resistant to ΦStaph1N (right panel). C. ΦStaph1N-treated, evolved MRSA strains show significant loss of resistance against oxacillin, compared to the parental strains. Loss of resistance is indicated by the area of bacterial clearance surrounding the antibiotic resistance strip. D. ΦStaph1N treatment causes loss resistance against different β-lactams. Plotted are the fold reductions of minimal inhibitory concentration (MIC) between treated and mock-treated cells. OXI = oxacillin; CEF = cefazolin; AMX = amoxicillin; AMX+CA = amoxicillin & clavulanic acid; VANC = vancomycin.